American Association of Diabetes Educators Receives $2.25 Million Grant
From the Bristol-Myers Squibb Foundation
Four-Year Program Will Evaluate Effectiveness of Diabetes Self-Management Support
In Underserved Populations
For Release: August 7, 2013
The American Association of Diabetes Educators (AADE) announced today that it has received a $2.25 million grant from the Bristol-Myers Squibb Foundation for a four-year program to study the efficacy of diabetes self-management support (DSMS) in conjunction with formal diabetes self-management education (DSME) in underserved populations.
DSME is a process through which people with diabetes learn how to modify their behaviors and monitor their diet and blood glucose levels in order to manage their condition. DSMS may engage both the participant and family/friends in activities such as grocery shopping trips, preparation of family meals or neighborhood walks. The goal is to tailor the support to the individual participant’s preferences and needs to encourage positive diabetes self-care behavior.
“We hypothesize that people with type 2 diabetes who participate in DSME and receive a year of semi-structured support will sustain improvements in diabetes-related knowledge, self-care behaviors and clinical measures versus people with diabetes who participate in DSME but do not receive ongoing support,” said AADE President Tami Ross, RD, LD, CDE.
AADE will use the funds to test this theory:
- Provide DSME to 512 persons with type 2 diabetes from disproportionately impacted or underserved populations and communities. Participants will be served through Federally Qualified Health Centers (FQHC) or similar sites.
- Provide a full year of semi-structured DSMS to half of the participants (256 individuals) following their participation in DSME.
- Collect outcome measures (behavioral, clinical, diabetes knowledge, self-reported quality of life and diabetes-specific quality of life) on all participants at multiple points over a 2.5 year period (6 months of DSME, 12-month DSMS period, 12-month follow-up period).
- Assess the impact that the addition of DSMS provides in terms of longevity in health outcomes improvement.